Evidence map›Paper›PMID 39337361›Full record

ArticleInternational journal of molecular sciences2024

The Role of Mutated Calreticulin in the Pathogenesis of

Roberta Vadeikienė, Baltramiejus Jakštys, Danguolė Laukaitienė, Saulius Šatkauskas, Elona Juozaitytė, Rasa Ugenskienė

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roberta VadeikienėOncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Baltramiejus JakštysResearch on Delivery of Medicine and Genes Cluster, Faculty of Natural Sciences, Vytautas Magnus University, LT-44001 Kaunas, Lithuania.ORCID 0000-0002-6106-330X
Danguolė LaukaitienėOncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
Saulius ŠatkauskasResearch on Delivery of Medicine and Genes Cluster, Faculty of Natural Sciences, Vytautas Magnus University, LT-44001 Kaunas, Lithuania.ORCID 0000-0002-9001-7767
Elona JuozaitytėInstitute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.ORCID 0000-0001-6695-7786
Rasa UgenskienėOncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloproliferative neoplasms (MPNs) are characterized by increased proliferation of myeloid lineages in the bone marrow. Calreticulin (

Indexed as

CalreticulinFusion Proteins, bcr-ablMutationMyeloproliferative DisordersDNA DamageHumansOxidative StressPhosphatidylinositol 3-KinasesSignal TransductionTOR Serine-Threonine KinasesBCR-ABL1 fusion protein, humanCalreticulinCALR protein, humanFusion Proteins, bcr-ablPhosphatidylinositol 3-KinasesTOR Serine-Threonine Kinasesapoptosiscalreticulincell cycleDNA damageHedgehogJAK/STATmyeloproliferative neoplasmsoxidative stressPI3K/Akt/mTOR

Identifiers

PMID39337361
PMCPMC11432199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.